A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
Clinical trial NCT03622112 · COMPLETED
Trial details
- NCT number
- NCT03622112
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2019-09-30
- Enrollment
- 808
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.